These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6332738)

  • 21. Sodium dependent [3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinsons disease.
    Schoemaker H; Pimoule C; Arbilla S; Scatton B; Javoy-Agid F; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):227-35. PubMed ID: 3927176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.
    Sershen H; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1985 Dec; 24(12):1257-9. PubMed ID: 3879338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]cocaine binding and inhibition of [3H]dopamine uptake is similar in both the rat striatum and nucleus accumbens.
    Boja JW; Kuhar MJ
    Eur J Pharmacol; 1989 Dec; 173(2-3):215-7. PubMed ID: 2625137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional and temporal effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine uptake sites in mouse brain.
    Donnan GA; Kaczmarczyk SJ; McKenzie JS; Rowe PJ; Kalnins RM; Mendelsohn FA
    J Neurol Sci; 1987 Nov; 81(2-3):261-71. PubMed ID: 3501002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of N-substituted phenyltetrahydropyridines on cerebral high-affinity synaptosomal uptake of dopamine and other monoamines in several mammalian species.
    Kula NS; Baldessarini RJ; Campbell A; Finklestein S; Ram VJ; Neumeyer JL
    Life Sci; 1984 Jun; 34(26):2567-75. PubMed ID: 6610812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
    Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
    J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
    Lau YS; Fung YK
    Brain Res; 1986 Mar; 369(1-2):311-5. PubMed ID: 3486026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of nicotine and amphetamine on the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice.
    Sershen H; Mason MF; Reith ME; Hashim A; Lajtha A
    Neuropharmacology; 1986 Nov; 25(11):1231-4. PubMed ID: 3491964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on age-related changes in dopamine turnover and transporter function in the mouse striatum.
    Sershen H; Mason MF; Hashim A; Lajtha A
    Eur J Pharmacol; 1985 Jul; 113(1):135-6. PubMed ID: 3876226
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral versus parenteral efficacy of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): differential effects on depletion of heart norepinephrine and of striatal dopamine in mice.
    Fuller RW; Hemrick-Luecke SK
    Biochem Pharmacol; 1987 Mar; 36(6):789-92. PubMed ID: 3494450
    [No Abstract]   [Full Text] [Related]  

  • 31. Sodium-independent binding of [3H]cocaine in mouse striatum is serotonin related.
    Reith ME; Meisler BE; Sershen H; Lajtha A
    Brain Res; 1985 Sep; 342(1):145-8. PubMed ID: 4041805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Holmer HK; Keyghobadi M; Moore C; Meshul CK
    Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine.
    Schmidt CJ; Matsuda LA; Gibb JW
    Eur J Pharmacol; 1984 Aug; 103(3-4):255-60. PubMed ID: 6333347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW; Robertson DW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic analgesics and other phenylpiperidines: effects on uptake and storage of dopamine and other monoamines mouse forebrain tissue.
    Baldessarini RJ; Kula NS; Francoeur D; Finklestein SP; Murphy F; Neumeyer JL
    Life Sci; 1986 Nov; 39(19):1765-77. PubMed ID: 3490612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
    Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
    Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine blocks the dopamine depletion induced by MPTP.
    Mayer RA; Jarvis MF; Wagner GC
    Res Commun Chem Pathol Pharmacol; 1985 Jul; 49(1):145-8. PubMed ID: 3875884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment.
    Ricaurte GA; Langston JW; Delanney LE; Irwin I; Peroutka SJ; Forno LS
    Brain Res; 1986 Jun; 376(1):117-24. PubMed ID: 3487376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.